Both in Medical Labs
GRAIL vs Caris Life Sciences
Over the past year GRAL returned +78.0% and CAI returned +6.5%; their daily moves had a correlation of 0.35.
GRAL +78.0% CAI +6.5%Growth of $1, one year, split-adjusted
| Metric | GRAL | CAI |
|---|---|---|
| Price | $143.66 | $33.22 |
| Market cap | $6.42B | $9.39B |
| Today | +3.03% | +1.13% |
| 1 month | +4.6% | +21.0% |
| 6 months | +128.9% | +73.7% |
| Year to date | +67.8% | +23.1% |
| 1 year | — | +11.0% |
| Revenue growth (YoY) | +25.7% | +45.4% |
| Gross margin | −28.1% | 68.1% |
| Net margin | −246.7% | −0.2% |
| P/E (TTM) | — | 89.3× |
| Price / sales | 38.8× | 9.5× |
| Net cash | $861.6M | $400.0M |
| Dividend yield | — | — |
| Volatility (60d) | 96.8% | 64.7% |
| Short % of float | 19.3% | 12.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).